STAT

Pharma tries to cash in on migraine market by making new drugs free, for now

With intense competition in the market for new migraine headache drugs, some companies are making their medicines free to patients with private insurance.

With approval of a new migraine therapy, Eli Lilly has become the third drug company angling for dominance in what could become a multibillion-dollar market for preventing debilitating headaches. But because none of the three medicines is clearly better than another, the contenders are taking a novel approach to competition: giving drugs away for free.

Lilly’s treatment, called Emgality, is an

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readScience
To Sleep, Perchance To Forget? Scientists Pinpoint In Mice The Neurons That Control Memory While Dreaming
If you wonder why we forget our dreams, new research in mice might answer that question and others related to memory.
STAT4 min read
Opinion: Cokie Roberts: A Beacon For Cancer Survivors Like Me
In full view of her ABC News audience and on the air at NPR, Cokie Roberts lived publicly with breast cancer for 17 years. That's a victory, even if she…
STAT2 min readPolitics
Trump Says It’s ‘Great To See’ Pelosi’s Drug Pricing Plan
President Trump said it was “great to see” Pelosi’s new drug pricing plan — the same one many other Republicans called “socialist” on Thursday.